Reduction, Refinement, and Replacement Leadership Group (3Rs LG)
Owner/Developer: International Consortium for Innovation and Quality in Pharmaceutical Development (IQ Consortium)
|Country:||United States of America|
Established in January 2012, the Reduction, Refinement, and Replacement Leadership Group (3Rs LG) is an association of senior veterinarians and 3Rs specialists from IQ member companies that meet on a regular basis to review and discuss common scientific and regulatory issues and topics surrounding the use of animals. The mission of the 3Rs Leadership Group is to promote sharing and integration of science and technology to advance the Reduction, Refinement, and Replacement of animals used in the discovery and development of new medicines, vaccines, medical devices and health care products for humans and animals.
The International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) is a technically-focused organization of pharmaceutical and biotechnology companies with a mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.
|Channel:||Website - Face-to-face|
|User access:||Open access|
|Relevance:||Replacement - Reduction - Refinement|
|Purpose:||Documentation and information|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.